By Drug Target Review2025-08-08T08:30:21
A new study from the Van Andel Institute shows that glucose not only fuels T cells but also strengthens their internal signalling and cancer-fighting capabilities –offering a potential route to improved immunotherapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2023-05-31T15:16:10
Sponsored by Bio-Techne
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2024-01-09T09:30:19
Sponsored by Sartorius
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-03-08T16:29:20
Sponsored by Bio-Techne
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud